학술논문
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
Document Type
Article
Author
Source
In: Clinical Breast Cancer . (Clinical Breast Cancer, April 2020, 20(2):89-97)
Subject
Language
English
ISSN
19380666
15268209
15268209